期刊文献+

变应性鼻炎免疫治疗前后外周血不同T细胞亚群基因表达的研究 被引量:6

Gene expression pattern of different T cell subsets before and after specific immunotherapy in allergic rhinitis patients
下载PDF
导出
摘要 目的探讨变应性鼻炎(AR)屋尘螨特异性免疫治疗前后外周血调节性T细胞(T regulatory cells,Treg)Foxp3基因和γδT细胞抗原识别受体(T cell receptor,TCR)Vγ亚家族基因表达的变化情况。方法选择22例屋尘螨皮下注射免疫治疗1年有效的AR患者,采用RT-PCR检测治疗前后外周血Foxp3与TCR VγⅠ~Ⅲ基因表达水平。10例健康志愿者为对照。结果 22例AR患者免疫治疗前Foxp3、TCR VγⅠ~Ⅲ水平明显低于对照组(Z=-2.155,Z=-2.114,t=4.101、t=3.108,P均〈0.05),治疗后Foxp3、VγⅢ明显升高(t=-4.577,Z=-3.416,P均〈0.05);治疗前Foxp3与VγⅠ、Ⅱ、Ⅲ呈正相关,治疗后Foxp3与VγⅢ呈正相关。结论免疫治疗1年有效的AR患者中,治疗前后外周血Treg细胞和γδT细胞亚群之间存在动态平衡关系,患者免疫治疗早期症状的改善可能与T细胞的免疫重塑相关。 OBJECTIVE To investigate the expression pattern of Treg's Foxp3 gene and γδT cell receptor(TCR) Vγ subfamily genes in peripheral blood mononuclear cells(PBMCs) of allergic rhinitis(AR) patients before and after allergen-specific immunotherapy(SIT). METHODS Twenty-two AR patients undergoing effective SIT with house dust mite extract for one year were recruited. Real-time PCR was performed to detect the gene expression levels of Foxp3 and TCR Vγ subfamilies. Ten healthy volunteers were recruited as the controls. RESULTS The expression levels of Foxp3 and TCR VγⅠ, Ⅱ, Ⅲ in AR patients before SIT were significantly lower than those in healthy subjects(Z=-2.155, P〈0.05; Z=-2.114, P〈0.05; t=4.101, P〈0.05; t=3.108, P〈0.05, respectively). The expression levels of Foxp3 and TCR VγⅢ were obviously increased after SIT(t=-4.577, P〈0.05; Z=-3.416, P〈0.05). Before SIT, significant positive correlation was observed between expression levels of Foxp3 and VγⅠ, Ⅱ, Ⅲ. After SIT, significant positive correlation was observed between expression levels of Foxp3 and VγⅢ. CONCLUSION Treg and Vγ subfamily T cells were in a dynamic balance in the PBMCs of AR patients before and after effective immunotherapy for one year. The early improvement of symptoms following immunotherapy might be associated with the remodeling of T cell immunity.
出处 《中国耳鼻咽喉头颈外科》 CSCD 2014年第9期477-480,共4页 Chinese Archives of Otolaryngology-Head and Neck Surgery
基金 国家自然科学基金(81371072) 广东省自然科学基金(S2013010016386)联合资助
关键词 变态反应和免疫学 鼻炎 变应性 常年性 抗原 尘螨属 脱敏法 免疫 T淋巴细胞 调节性 Allergy and Immunology Rhinitis Allergic Perennial Antigens Dermatophagoides Desensitization Immunologic T-Lymphocytes Regulatory
  • 相关文献

参考文献19

  • 1Nouri-Aria KT. Foxp3 expressing regulatory T-cells in allergic disease. Adv Exp Med Biol, 2009, 665: 180-194.
  • 2Kay AB. Allergy and allergic diseases. Second of two parts. N Engl J Med, 2001, 344: 109-113.
  • 3Cook L, Miyahara N, Jin N, et al. Evidence that CD8+ dendritic cells enable the development of gammadelta T cells that modulate airwayhyperresponsiveness. J Immunol, 2008, 181: 309- 319.
  • 4Yang Q, Li P, Li Y, et al. Effects of immunotherapy on the distribution and clonality of TRC Vy and V8 subfamily T cells in allergic rhinitis patients. J Med Biochem, 2012, 31: 94-99.
  • 5Korematsu S, Tanaka Y, Nagakura T, et al. Human gammadelta T cells modulate the mite allergen-specific T-helper type 2-skewed immunity. Clin Exp Allergy, 2007, 37: 1681-1687.
  • 6Petermann F, Rothhammer V, Claussen MC, et al. ),8 T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependentmechanism. Immunity, 2010, 33: 351-363.
  • 7中华耳鼻咽喉头颈外科杂志编委会鼻科组,中华医学会耳鼻咽喉头颈外科学分会鼻科学组.变应性鼻炎诊断和治疗指南(2009年,武夷山).中华耳鼻咽喉头颈外科杂志,2009,44:977-978.
  • 8Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA (2)LEN and AllerGen). Allergy, 2008, 63: 8-160.
  • 9王成硕,张罗,韩德民,王向东,赵岩,周兵,刘健慧.标准化尘螨变应原疫苗治疗变应性鼻炎一年的疗效和安全性研[J].中国耳鼻咽喉头颈外科,2007,14(1):3-6. 被引量:61
  • 10Chen S, Zha X, Yang L, et al. Deficiency of CD3gamma, delta, epsilon and zeta expression in T-cells from AML patients. Hematology, 2011, 16: 31-36.

二级参考文献6

共引文献61

同被引文献35

  • 1顾之燕,董震.变应性鼻炎的诊治原则和推荐方案(2004年,兰州)[J].中华耳鼻咽喉头颈外科杂志,2005,40(3):166-167. 被引量:1692
  • 2赵建东,王世振,马凤梅.Th1和Th2细胞及相关细胞因子在变应性鼻炎发病中的变化[J].临床耳鼻咽喉科杂志,2005,19(17):794-796. 被引量:31
  • 3ZHAO J,BAI J,SHEN K,et al.Self-reported prevalence of childhood allergic diseases in three cities of China:a multicenter study[J].BMC Public Health,2010,10:551-551.
  • 4VIGNALI D A,KUCHROO V K.IL-12family cytokines:immunological playmakers[J].Nat Immunol,2012,13:722-728.
  • 5COLLISON L W,CHATURVEDI V,HENDERSON A L,et al.IL-35-mediated induction of a potent regulatory T cell population[J].Nat Immunol,2010,11:1093-1101.
  • 6KSER T,MLLEBNER A,HARTL R T,et al.Porcine T-helper and regulatory T cells exhibit versatile mRNA expression capabilities for cytokines and co-stimulatory molecules[J].Cytokine,2012,60:400-409.
  • 7WHITEHEAD G S,WILSON R H,NAKANO K,et al.IL-35 production by inducible costimulator(ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease[J].J Allergy Clin Immunol,2012,129:207-215.
  • 8YANG Y,XUAN M,ZHANG X,et al.Decreased IL-35levels in patients with immune thrombocytopenia[J].Hum Immunol,2014,75:909-913.
  • 9SHEN H,WANG C,FAN E,et al.Upregulation of interleukin-35subunits in regulatory T cells in a murine model of allergic rhinitis[J].ORL J Otorhinolaryngol Relat Spec,2014,76:237-247.
  • 10TAAMS L S,PALMER D B,AKBAR A N,et al.Regulatory T cells in human disease and their potential for therapeutic manipulation[J].Immunology,2006,118:1-9.

引证文献6

二级引证文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部